
ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOcjdSMU1KWDd3TmJfa3FJQWNnMUZDckMxc0RmVHpabS1VVXdCaFI3cGlTUDE0TTgtSmpyeG5GLVV2VkZCaE5TSnZpTUx6V1EwM3RVRmt2ZUpnVlcyR3JYTlFUTFVTWVNSNE5meFh6SlVuVW9sc3BoNEpSWWNBazNKZkgtZ1k2M3VrN1dwLUFLRTZEUHdpQVpiX3VaMUo1YXh4LTVaakV0emVpdlc0Z2Mtc2plTHUxU0ZiUWpj?oc=5" target="_blank">ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>
